metabolic · Mechanism Report
Does rs41272114 CC indicate absence of the low-production T allele?
The CC genotype at rs41272114 indicates the individual does not carry the T loss-of-function allele that lowers Lp(a) production.
This is what AI claimed
The LPA rs41272114 T allele is a loss-of-function variant associated with lower lipoprotein(a) levels, so rs41272114 CC is consistent with absence of this low-production allele.
Executive summary
The claim states that the rs41272114 T allele is a splice-site loss-of-function variant that reduces apo(a) synthesis and therefore lowers circulating Lp(a). The CC genotype, by definition, lacks the T allele and is consistent with the reference (standard-production) state at this locus, meaning this specific genetic brake on Lp(a) is absent.
Verified conclusion
The LPA gene, which encodes apolipoprotein(a), is the primary genetic determinant of circulating lipoprotein(a) [Lp(a)] levels. The rs41272114 variant is a key single nucleotide polymorphism (SNP) used to refine genetic predictions of an individual's Lp(a) profile.
Clinical and genetic findings
Evidence confirms that the rs41272114 SNP is a primary causal driver of plasma Lp(a) concentrations.
- Genotype interpretation: The CC genotype represents the wild-type or reference state. The presence of the T allele (often referred to as the minor A allele in some nomenclature) is strongly associated with significantly reduced Lp(a) levels.
- Association with Lp(a) levels: In large cohort studies, such as the Cooperative Health Research in the Region of Augsburg (KORA) F4 study, rs41272114 has been identified as a major determinant of Lp(a) variance. It is frequently included in high-accuracy predictive models alongside kringle IV type-2 (KIV-2) copy numbers to estimate serum concentrations.
- Absence of the variant: An individual with the rs41272114 CC genotype does not carry the low-production T allele. Consequently, this genotype is consistent with the "high-production" reference state at this specific locus, meaning this particular genetic brake on Lp(a) production is absent.
Mechanistic explanations
The rs41272114 T allele functions as a loss-of-function variant through the disruption of normal protein synthesis.
- Splice-site disruption: The T allele (c.4925G>A) acts as a splice-site variant. This mutation interferes with the standard mRNA splicing process, which is a critical step in the production of functional apolipoprotein(a).
- Impact on apo(a) secretion: By disrupting splicing, the T allele leads to a substantial decrease in the production and subsequent secretion of apo(a) into the plasma. This mechanism places rs41272114 in a category of variants—alongside nonsense mutations (e.g., R21X) and other splice-site mutations—that effectively lower Lp(a) levels regardless of the individual's KIV-2 copy number.
Bottom line
The rs41272114 T allele is a validated loss-of-function splice-site variant that significantly lowers Lp(a) production. Therefore, a CC genotype confirms the absence of this specific low-production allele, representing the standard-production genetic state at this locus.
References
- Comprehensive analysis of the genetic variation in the LPA gene from short-read sequencing — mdpi.com
- Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population — dx.plos.org
- Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes. — linkinghub.elsevier.com
- Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels. — pmc.ncbi.nlm.nih.gov
- The kringle IV type 2 domain variant 4925G>A causes the elusive association signal of the LPA pentanucleotide repeat — linkinghub.elsevier.com
- Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene — pmc.ncbi.nlm.nih.gov
- Prevalence and influence of LPA gene variants and isoform size on the Lp(a)-lowering effect of pelacarsen. — linkinghub.elsevier.com
- Comprehensive analysis of the genetic variation in the LPA gene from short-read sequencing — medrxiv.org
See a full patient report verified like this
Book a walkthrough